Safety and Tolerability Study of PF-06835375 in Subjects with Seropositive Systemic Lupus Erythematosus or Rheumatoid Arthritis
Safety and Tolerability Study of PF-06835375 in Subjects with Seropositive Systemic Lupus
Erythematosus or Rheumatoid Arthritis. [A Phase 1, Randomized, Multi-Center, Double-Blind,
Sponsor Open, Placebo-Controlled, Single and Multiple Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06835375 in Subjects with Seropositive Systemic Lupus Erythematosus or Rheumatoid Arthritis.
Category & Conditions: Immune System Diseases and Conditions
Medicine: PF-06835375
ClinicalTrials.gov Identifier (NCT): NCT03334851
Protocol ID: C1131001
PrintDownloadOpen Plain Language Summary Result: Click here